Replies to post #8938 on Momenta Pharmaceuticals, Inc. (MNTA)

[joethdo]

I'm all for diversity but I think Wheeler is taking it a bit too far, LOL. From the transcript:

"The approach should allow us to take full advantage of our advanced characterization technology. The agency recognizes the importance of an African providing structural and functional characterization data as a means for reducing uncertainty and reducing our perhaps even waiting clinical development requirement."